30
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
3512562
319423
2
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Creare
Create a timeline
Public timelines
Library
FAQ

1 gen 2013 anni - Ado-Trastuzumab Emtansine (T-DM1)

Descrizione:

For the treatment of patients with HER2-positive breast cancer previously treated with trastuzumab and/or a taxane drug, the FDA recommends ado-trastuzumab emtansine (T-DM1).

Aggiunto al nastro di tempo:

Cancer

ByTrinity Ozias
14 nov 2019

Data:

1 gen 2013 anni
Adesso
~ 11 years ago
About & FeedbackAccordoPrivatezzaBiblioteca
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on Trustpilot.com